New CFO To Seek Funding For Cash-Strapped Hyseq, after Q1 Revenues Rise | GenomeWeb

NEW YORK, April 27 – Hyseq has less than $15 million in the bank—drawn from a $20 million loan provided by Chairman George Rathman in February, but Peter Garcia, the new chief financial officer, is optimistic about the company’s future.

“The company to me seems undervalued,” said Garcia. “There is potential for significant growth over the next few years.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.